Product Compliance And Certification For Medical Device In India

Scope and evidence must be confirmed before any paid tests or filings.

India does not grant one universal ‘medical device certificate’. The route depends on the manufacturer's intended medical purpose, the precise device and variants, risk class, whether it is imported or made in India, and any independent controls over components or use. The Drugs and Cosmetics Act, 1940 and Medical Devices Rules, 2017 (MDR) are the starting point; read the current amendments, not the 2017 text in isolation.

Set the product boundary before assigning an Indian risk class

Freeze the intended-use statement, claims, patient population, user, clinical environment and mode of action. Indian regulation can cover hardware, a material or implant, an accessory and medical-purpose software. A diagnostic reagent or sample-analysis system calls for the separate in-vitro diagnostic (IVD) classification rules. A principal pharmacological, immunological or metabolic action requires a drug/device boundary assessment rather than automatic MDR treatment. Do not classify solely by a foreign CE mark, US FDA status, trade name or customs code.

Questions that change the route

Does the label claim diagnosis, treatment, monitoring, life support, disinfection of another medical device or contraception?
Is it an IVD, an implant, an active measuring device, standalone medical software, an accessory or a combination with a medicinal substance?
Is it sterile as supplied, does it measure, touch patients, penetrate tissue or remain implanted? For how long?
Which CDSCO First Schedule rule and current device-specific classification notice apply to this exact intended use?
Will each version be imported, manufactured locally or supplied by a contract manufacturer; who holds the Indian licence or registration?
Does the equipment emit ionising radiation, include a separately regulated telecom function, or fall under a specific mandatory BIS order?

CDSCO’s July 2026 medical-device-software guidance distinguishes medical-purpose functions from general wellness or fitness tracking without a medical purpose. It expressly describes existing MDR practice, not a new legal approval category. Document the claims and what the software actually does before selecting a device route.

Cross-regime route matrix for an Indian launch

Treat these as conditional branches, not a list of certificates that every device must obtain. Classes A, B, C and D reflect increasing risk; use Part I of the MDR First Schedule for devices and Part II for IVDs, together with applicable CDSCO classification lists.

Product/transaction trigger	Likely regulatory layer and responsible route	What must be resolved before launch
Non-IVD device, licensed class A/B, made in India	State Licensing Authority manufacturing licence (MD-5/MD-6 route); class B notified-body audit requirements apply as prescribed.	Document class, site, QMS and product scope; do not assume every class A product follows licensing.
Non-IVD device, class C/D, made in India	CDSCO Central Licensing Authority manufacturing licence (MD-9/MD-10 route).	Resolve higher-risk technical evidence and inspection before commercial manufacture.
Licensed device imported from overseas	Eligible Indian authorised agent applies for CDSCO import licence using MD-14; approval is MD-15.	Confirm site, model grouping, Indian agent eligibility, power of attorney and dossier.
Class A, non-sterile AND non-measuring	Specific licensing exemption; manufacturer or importer must obtain CDSCO device registration number under Chapter IIIB, if the product truly qualifies.	Match intended use and variants to the 31 Oct 2025 CDSCO classification list; sterile or measuring variants do not inherit this exemption. QMS is part of the 2026-amended registration declarations.
Test, reagent or instrument used for in-vitro diagnosis	IVD pathway under MDR First Schedule Part II and CDSCO IVD rules.	Determine analytes, sample, intended users, performance evidence and whether it is a new IVD.
Software or networked medical function	CDSCO assessment of medical purpose and software classification; separate telecom/BIS review only if the exact notified product/function is covered.	Preserve versioned intended use, validation, cybersecurity and interface specifications.
Device or module transmitting radio signals (for example Wi-Fi or Bluetooth)	Check WPC/DoT radio-frequency authorization or Equipment Type Approval (ETA) where applicable; evaluate MTCTE separately only if the product falls within a notified telecom category.	Record the radio module, operating bands, RF test evidence, Indian applicant and import configuration; connectivity alone neither proves nor rules out WPC/MTCTE applicability.
Diagnostic X-ray or other radiation equipment	CDSCO device pathway plus applicable AERB approvals/consents for manufacturer, supplier and/or user.	Identify model/type approval, supply and installation responsibilities; an MD-15 alone does not authorise clinical operation.
Electronics, components and accessories	Check BIS compulsory product orders and notified TEC/MTCTE scopes product by product, in addition to MDR where applicable.	A listed Indian Standard, ISO certificate or CE mark alone does not prove a separate BIS/TEC certificate is compulsory or satisfied.

Do not confuse product standards with separate certification. MDR rule 7 sets a hierarchy: applicable BIS/Ministry-notified standards, then ISO/IEC or pharmacopoeial standards if none applies, and validated manufacturer standards if neither applies. A separate mandatory BIS certification is a different question governed by the exact compulsory product order; neither an ISO certificate nor compliance with rule 7 alone proves such certification is required or obtained.

Three supply configurations that change the Indian device route

This is a triage example, not an official classification of a named product:

Version under review	Decision that changes	Evidence to obtain
Reusable non-sterile, non-measuring instrument	Class A registration might apply, only if intended use matches the relevant CDSCO entry.	Catalogue description, instructions, material, cleaning claims and exact CDSCO list entry.
Same instrument sold sterile	The class A non-sterile/non-measuring exemption cannot be carried over.	Sterilisation validation, sterile label, manufacturing-site/outsourcing details and fresh licence-route assessment.
Same form factor with a measurement function	The exemption cannot be carried over merely because the physical shape is unchanged.	Accuracy/measurement claims, calibration and performance validation, new classification rationale.

A non-sterile device intended to be sterilised by the hospital before use is not automatically a device “supplied sterile”. CDSCO’s explanatory FAQ distinguishes the supply state from the later process: review the non-sterile label, packaging and instructions for the specified pre-use sterilisation method. Whether Class A non-sterile/non-measuring registration applies still requires a separate risk-class and measurement check.

Who supplies the Indian registration, licence and model evidence

Prepare one controlled dossier index per manufacturing site and device family; do not equate a sales brochure with a Device Master File. The Fourth and Fifth Schedules define documents and QMS obligations by route.

Manufacturer: signed intended use, risk rule, model/accessory/variant map, design description, material and patient-contact profile.
Manufacturer: risk management, relevant bench/electrical/biological/sterility or software validation, clinical or performance evidence appropriate to the device.
Manufacturer/site: site or plant master file, applicable Device Master File, essential-principles checklist, QMS records and manufacturing/sterilisation chain.
Importer/authorised agent: documented Indian authorisation, eligible local licence or MD-42 status as applicable, overseas site credentials and free-sale evidence where prescribed.
Regulatory lead: dated CDSCO classification-list citation, chosen forms and any additional permission for investigational or new devices/IVDs.
Commercial team: artwork, IFU, packaging levels, importer details, batch/lot or serial traceability, storage and complaint/recall contacts.
Cross-regime lead: AERB, BIS or TEC applicability decision with the precise equipment model and official notified scope, not an assumed blanket approval.

For a licensed import under MDR rule 34, verify that the Indian authorised agent holds the qualifying manufacturing/wholesale licence or MD-42 registration, as applicable, and that the overseas manufacturing site is correctly covered. This eligibility question is different from the Chapter XI selling-premises exemption for qualifying Class A non-sterile, non-measuring products; do not substitute one for the other.

The Fifth Schedule’s QMS obligations and a third-party ISO 13485 certificate are not synonymous. CDSCO’s explanatory FAQ states that an ISO 13485:2016 certificate is not itself a universal prerequisite for an MDR manufacturing licence; applicable regulatory QMS duties still need to be met.

Labels and outsourced sterilisation can block release of a licensed device

MDR rule 44 covers device identity, intended identification/use, manufacturer/site, quantity, manufacture/expiry information subject to exceptions, batch/lot, relevant storage, sterile state and method, warnings, single-use status and Indian licence/importer information. Imported packs may need compliant stickers. Check each packaging level and IFU against the licensed device and actual supply condition; a CE symbol does not replace Indian labelling.

August 2026 amendments matter: G.S.R. 743(E) adds rule 44(p), requiring the licence number of an outsourced sterilisation site on the label where a manufacturer outsources sterilisation to another licensed facility; the stated mandatory compliance starts six months after the 14 August 2026 notification. G.S.R. 744(E) adds QMS references to class A non-sterile/non-measuring registration declarations (rules 19H/19J). Neither update turns a registration exemption into an exemption from safety, performance or traceability controls.

The rule specifies the English label prefixes “Sterilization sites Manufacturing License Number”, “Ster. Mfg. Lic. No.” or “S.M. L.”; verify the actual license number and final artwork before the requirement becomes mandatory.

The same G.S.R. 743(E) inserted a Ninth Schedule of government medical-device test/evaluation charges linked to rules 19 and 69. These are conditional charges for the specified testing/evaluation activity, not a flat certification price for every device.

Five CDSCO and parallel-regulator launch gates

Classify: sign off one intended-use/variant/risk matrix and verify the latest CDSCO notices; seek CDSCO classification through its online facility if genuinely unresolved.
Assign holder: specify manufacturer, manufacturing site, importer/authorised agent and seller; verify the applicable local permission, MD-42 or selling-premises status.
Map approvals: choose CDSCO licence versus class A registration and separately screen IVD, AERB, mandatory BIS and notified TEC where relevant.
Close evidence and labelling: reconcile tests, QMS, declarations, clinical/performance justification, site details and every India-bound label/IFU version.
Release only after documented prerequisites: confirm actual grant/registration, product and site coverage, import/customs prerequisites and downstream supply controls; keep renewal/retention and vigilance ownership recorded.

When an Indian device licence or registration needs reassessment

Reassess before expanding indications, adding a sterile or measuring variant, changing materials or implant duration, altering a software clinical function, moving manufacturing/sterilisation sites, appointing a new importer or adding a product to an existing licence. Depending on the change and applicable rules, an amendment, additional device permission or new filing may be needed. Retain complaint investigations, field actions and adverse-event escalation records. A foreign approval or unchanged catalogue code does not settle the Indian change decision.

For an exclusively wearable product, the adjacent India wearable medical-device route map focuses on sensors, body-worn operation and software-specific decisions. This page instead coordinates the full medical-device product stack, including implants, instruments, IVD boundaries and radiation equipment.

Official texts to verify against the exact device

Questions manufacturers and Indian importers ask

Does an EU CE mark or US FDA clearance replace a CDSCO licence?

No. Foreign evidence may support the Indian dossier or a rule-specific clinical-investigation provision, but it is not general permission to import or sell. Rule 63 and rule 36 must be assessed separately; the August 2026 rule 63 amendment includes EU countries in a specified exception, not blanket recognition.

Can we register all Class A devices without a manufacturing or import licence?

No. The Chapter IIIB route is for qualifying Class A devices that are both non-sterile and non-measuring. Check the current CDSCO list and exact intended use; a sterile or measuring variant requires a fresh route decision.

If we outsource sterilisation, whose licence number is needed on the box?

Where rule 44(p) applies, it is the licensed outsourced sterilisation site's licence number, using the specified labelling wording. Review the six-month commencement condition and your actual manufacturing arrangement.

Is an import licence enough to install and operate a diagnostic X-ray unit?

No. AERB imposes separate requirements for radiological equipment, suppliers and facilities, including the applicable consents before clinical operation.

Do all connected medical devices need BIS or telecom certification?

No general conclusion is possible from connectivity alone. Match the exact electronics or telecom equipment and functionality to currently compulsory BIS orders and notified MTCTE equipment; resolve CDSCO medical software classification independently.

Does a reseller of Class A non-sterile, non-measuring devices always need Form MD-42?

No. CDSCO expressly states that qualifying Class A non-sterile and non-measuring devices are exempt from MDR Chapter XI (sale of medical devices), including the MD-42 requirement. The manufacturer/importer still needs Chapter IIIB device registration. Do not extend the exemption to other device classes or variants.